Computer-aided detection (CAD) software developer and clinical trial image interpretation and management firm Median Technologies has received a contract from pharmaceutical firm Sanofi.
Under the deal, Median will provide medical interpretation and management services for a new Sanofi phase II study on small-cell lung cancer. In the trial, imaging data will be acquired in 65 investigator sites in 15 countries with an anticipated total enrollment of 150 to 200 patients, Median said.
Median's Lesion Management Solutions (LMS) platform will be installed at all 65 investigator and independent review sites.
